| 新型冠状病毒病疫情期间乳腺癌患者的术后辅助放疗 |
| |
| 引用本文： | 房辉,王淑莲,李晔雄. 新型冠状病毒病疫情期间乳腺癌患者的术后辅助放疗[J]. 中华放射肿瘤学杂志, 2020, 29(5): 321-323. DOI: 10.3760/cma.j.cn113030-20200228-00001 |
| |
| 作者姓名： | 房辉 王淑莲 李晔雄 |
| |
| 作者单位： | 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科 100021 |
| |
| 摘 要： | 乳腺癌是中国女性发病率最高的恶性肿瘤,术后辅助放疗是乳腺癌综合治疗的重要组成部分。新型冠状病毒病疫情给乳腺癌的放疗带来很大的挑战。新型冠状病毒感染的患者中,院内感染占很大比重。新型冠状病毒感染的肿瘤患者比非肿瘤患者的极重症比例高。在新型冠状病毒病疫情期间,为减少患者感染的风险,需要从严掌握放疗指征,必要时可以适当延迟放疗。必须放疗时,建议采用大分割放疗模式。
|
| 关 键 词： | 乳腺癌 辅助放疗 新型冠状病毒病 疫情 |
| 收稿时间： | 2020-02-28 |
Strategies of adjuvant radiotherapy for patients with breast cancer in COVID-19 disease outbreak |
| |
| Fang Hui,Wang Shulian,Li Yexiong. Strategies of adjuvant radiotherapy for patients with breast cancer in COVID-19 disease outbreak[J]. Chinese Journal of Radiation Oncology, 2020, 29(5): 321-323. DOI: 10.3760/cma.j.cn113030-20200228-00001 |
| |
| Authors: | Fang Hui Wang Shulian Li Yexiong |
| |
| Affiliation: | Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China |
| |
| Abstract: | Breast cancer is the most common malignancy in women in China, and adjuvant radiotherapy is an important component of multidisciplinary treatment. The 2019 novel coronavirusdisease(COVID-19) poses a significant challenge for patients to complete radiotherapy, because of a high hospital-related transmission rate of COVID-19 and a high risk of severe events for cancer patients. In this comment, we propose three major strategies for adjuvant radiotherapy in this COVID-19 outbreak:omission of radiotherapy, postponing of radiotherapy, and hypofractionated radiotherapy. |
| |
| Keywords: | Breast neoplasm Adjuvant radiotherapy 2019 novel coronavirus disease Disease Outbreaks |
| 本文献已被 维普 等数据库收录！ |
| 点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息 |
|
点击此处可从《中华放射肿瘤学杂志》下载全文 |
